Pain Management

    Pain Management Market Research Reports

    Titlepublishedprice

    Pain Partnering 2009-2014

    By Current Partnering
    "......e majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors pain technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization......"
    1-Aug-2014$1995

    Inflammatory Pain – Pipeline Review, H2 2014

    By Global Markets Direct
    "......therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development f......"
    31-Jul-2014$2000

    Acute Pain – Pipeline Review, H2 2014

    By Global Markets Direct
    "......nt by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Acute Pain and spe......"
    31-Jul-2014$2000

    Chronic Pain – Pipeline Review, H2 2014

    By Global Markets Direct
    "......sessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Chronic Pain......"
    31-Jul-2014$2000

    Post-Operative Pain – Pipeline Review, H1 2014

    By Global Markets Direct
    "......ages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic develop......"
    30-Jun-2014$2000

    Pain and Fever Relief Drugs Markets in China

    By AMID
    "......ndustry structure, marketing channels and major industry participants. Historical data (2003, 2008 and 2013) and long-term forecasts through 2018 and 2023 are presented. Major producers in China are profiled......."
    1-Jun-2014$4000

    Moderate Pain – Pipeline Review, H1 2014

    By Global Markets Direct
    "...... assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Moderate ......"
    30-May-2014$2000

    Ocular Pain – Pipeline Review, H1 2014

    By Global Markets Direct
    "......sment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Ocular Pain and......"
    15-May-2014$2000

    PharmaPoint: Neuropathic Pain – US Drug Forecast and Market Analysis to 2022

    By GlobalData
    "......ropathic pain. Although the term neuropathic pain is used to describe a wide range of pain syndromes with varying etiologies, this report focuses on 3 distinct forms of NP: Painful diabetic neuropathy, Postherpetic neuralgia and trigeminal neuralgia......."
    30-Apr-2014$4995

    PharmaPoint: Neuropathic Pain – 5EU Drug Forecast and Market Analysis to 2022

    By GlobalData
    "......ropathic pain. Although the term neuropathic pain is used to describe a wide range of pain syndromes with varying etiologies, this report focuses on 3 distinct forms of NP: Painful diabetic neuropathy, Postherpetic neuralgia and trigeminal neuralgia......."
    30-Apr-2014$6995
    Live Chat
    Live Chat by Comm100